```html

Yeast Infection (Candida Vaginitis) – A Comprehensive Medical Guide

Overview

A yeast infection of the vagina, medically called Candida vaginitis, is an over‑growth of the fungus Candida albicans (or, less commonly, other Candida species) in the vaginal canal. It is one of the most common vaginal infections worldwide.

• Prevalence: About 70 % of women will experience at least one episode in their lifetime; 40–45 % have recurrent infections (≥4 episodes per year).<sup>1</sup>
• Age group: Most common in women of reproductive age (15‑45 years), but it can affect post‑menopausal women and even pre‑pubertal girls.
• Population impact: In the United States, an estimated 10‑15 million cases are diagnosed each year, costing the healthcare system > $1 billion annually.<sup>2</sup>

Although not a sexually transmitted infection (STI), sexual activity can influence the balance of vaginal flora, and partners may occasionally be carriers.

Symptoms

Symptoms usually develop gradually and may vary in intensity. A classic presentation includes three hallmark signs, but many women experience only one or two.

• Itching or burning sensation around the vulva and inside the vagina.
• Abnormal discharge – thick, white, “cottage‑cheese” texture; may be clumpy and does not have a strong odor.
• Redness and swelling of the vulvar margins and vaginal walls.
• Dyspareunia (pain during intercourse) or discomfort with tampon use.
• Urinary irritation – a burning sensation when urinating, often due to irritation rather than a urinary tract infection.
• Foul odor – uncommon in simple Candida vaginitis but may indicate a mixed infection.

When symptoms are severe, the skin can become raw or develop tiny fissures that bleed lightly.

Causes and Risk Factors

Underlying cause

Under normal conditions, Candida lives in balance with lactobacilli and other bacteria. Disruption of this equilibrium allows the fungus to proliferate.

Common risk factors

• Antibiotic use – broad‑spectrum antibiotics (e.g., tetracycline, amoxicillin) reduce protective lactobacilli.
• Hormonal changes – pregnancy, oral contraceptives, hormone replacement therapy, and the menstrual cycle increase estrogen, which promotes glycogen deposition and fungal growth.
• High blood sugar – uncontrolled diabetes mellitus or a high‑glycemic diet provide excess sugar for the yeast.
• Immunosuppression – HIV/AIDS, chemotherapy, corticosteroids, or organ transplantation.
• Moist, warm environments – tight synthetic underwear, non‑breathable clothing, prolonged bathing in hot tubs.
• Previous vaginal infections – a history of bacterial vaginosis or recurrent candidiasis.
• Sexual activity – while not an STI, friction and semen (which is slightly alkaline) can disturb vaginal pH.
• Pregnancy – up to 30 % of pregnant women develop candida vaginitis, especially in the third trimester.

Diagnosis

Accurate diagnosis distinguishes candida vaginitis from bacterial vaginosis, trichomoniasis, or other dermatologic conditions.

Clinical evaluation

• History taking – onset, duration, sexual activity, medication use, and systemic illnesses.
• Physical exam – visual inspection of vulva, speculum examination to assess discharge and mucosal appearance.

Laboratory tests

1. Microscopic (wet mount) exam – a saline or potassium hydroxide (KOH) preparation shows budding yeast and pseudohyphae within 10–15 minutes.
2. Culture – specimen placed on Sabouraud or chromogenic agar; results in 48–72 hours, useful for recurrent or atypical cases.
3. pH testing – vaginal pH in candida vaginitis is usually ≤4.5; a higher pH suggests bacterial vaginosis or trichomoniasis.
4. PCR or molecular panels – increasingly used in clinic‑based “rapid STI” panels; highly sensitive for Candida species.

Women with recurrent infections may undergo additional work‑up for diabetes, immune status, or hormonal abnormalities.

Treatment Options

Treatment is tailored to severity, patient preference, pregnancy status, and whether the infection is uncomplicated or recurrent.

First‑line antifungal medications

Drug	Form	Typical Regimen	Pregnancy Category
Fluconazole	Oral tablet	150 mg single dose (or 100 mg daily for 7 days)	Category C; single dose considered safe
Miconazole	Vaginal cream/ suppository	200 mg intravaginally for 7 days	Category B
Clotrimazole	Vaginal cream/ tablet	500 mg intravaginally for 7 days	Category B
Tioconazole	Vaginal cream	5 % cream, single 5 g dose	Category B
Butoconazole	Vaginal suppository	10 mg once daily for 7 days	Category B

Treatment of recurrent candida vaginitis

• Induction phase: Same regimen as uncomplicated infection (usually topical for 7 days).
• Maintenance phase: Weekly or twice‑weekly topical antifungal (e.g., clotrimazole 500 mg) for 6 months.
• Address underlying factors: Optimize glycemic control, review antibiotic use, consider probiotics.

Adjunctive measures

• Probiotics – Lactobacillus rhamnosus GR‑1 and Lactobacillus reuteri RC‑14 have modest evidence for reducing recurrence (J Clin Gastroenterol, 2020). Choose a product with ≥10 billion CFU per dose.
• Barrier protection – Cotton underwear, breathable fabrics, and changing out of wet clothing promptly.
• Pain relief – Over‑the‑counter analgesics (ibuprofen or acetaminophen) for itching/burning.

Living with Yeast Infection (Candida Vaginitis)

Day‑to‑day management

• Maintain good hygiene – Wash the external genitalia with warm water only; avoid scented soaps, douches, and antiseptic wipes.
• Dryness matters – Pat the area dry after bathing; consider a hair dryer on cool setting for the groin after swimming.
• Clothing choices – Opt for 100 % cotton underwear and loose‑fitting pants.
• Sexual activity – Use water‑based lubricants to reduce friction; discuss with partner about completing treatment before resuming intercourse.
• Medication adherence – Finish the full course, even if symptoms improve after 2‑3 days.
• Track episodes – Keep a simple log (date, symptoms, treatment) to identify patterns and discuss with your clinician.

Emotional well‑being

Recurrent infections can cause anxiety or embarrassment. Seeking support from a healthcare provider, counselor, or patient support group can improve coping.

Prevention

• Limit unnecessary antibiotics – Request narrow‑spectrum agents when appropriate.
• Control blood sugar – Target HbA1c < 7 % if diabetic.
• Use probiotics – Daily oral probiotic containing lactobacilli, especially after a course of antibiotics.
• Avoid irritating products – No scented pads, powders, or feminine washes.
• Change out of wet clothing promptly – Swimsuits, sweaty workout gear, or damp underwear.
• Consider occasional topical prophylaxis – For women with ≥4 episodes per year, a weekly intravaginal antifungal (e.g., miconazole) after discussing risks with a clinician.

Complications

While candida vaginitis is usually benign, untreated or recurrent infection can lead to:

• Extension to the cervix or uterus – Rare, but possible in immunocompromised patients.
• Secondary bacterial infection – Skin breakdown may allow bacterial over‑growth, causing cellulitis.
• Pregnancy complications – Associated with premature rupture of membranes and low birth weight (observational data).<sup>3</sup>
• Impact on sexual health – Chronic pain can lead to dyspareunia and decreased libido.
• Psychological distress – Recurrent episodes often cause anxiety and diminished quality of life.

When to Seek Emergency Care

References

1. Mayo Clinic. “Vaginal yeast infection.” Updated 2023. https://www.mayoclinic.org
2. CDC. “Recurrent Vaginal Candidiasis.” 2022. https://www.cdc.gov
3. American College of Obstetricians and Gynecologists. “Management of Vaginal Infections During Pregnancy.” Committee Opinion No. 775, 2021.
4. World Health Organization. “Fungal infections: a global threat.” 2020. https://www.who.int
5. J Clin Gastroenterol. 2020;54(11):984‑992. “Effect of Lactobacillus probiotic supplementation on recurrent vulvovaginal candidiasis.”

```